Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.05−0.23 (-3.16%)
Close on Nov 17, 2026Market cap $194.59MP/E –Yield –
Precision BioSciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Precision BioSciences's enterprise value was $154.32M on Nov 11, 2026, against $20.86M a year earlier. Over the last 5 years it ranged from -$105.95M to $284.18M, with a median of -$39.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $154.32M | +2761.0% |
| 2025 | Dec 31, 2025 | $5.39M | – |
| 2024 | Dec 31, 2024 | -$72.70M | – |
| 2023 | Dec 29, 2023 | -$80.00M | – |
| 2022 | Dec 30, 2022 | -$80.03M | -128.2% |
| 2021 | Dec 31, 2021 | $284.18M | -14.8% |
| 2020 | Dec 31, 2020 | $333.54M | -33.0% |
| 2019 | Dec 31, 2019 | $497.47M | – |
See a number that looks wrong?